Clifford Tabin

Tabin was educated at the University of Chicago where he was awarded a BS in physics in 1976. In Weinberg's lab, Tabin constructed murine leukemia virus, the first recombinant retrovirus that could be used as a eukaryotic vector. ==Career==

Following his PhD, Tabin did postdoctoral research with Douglas A. Melton at Harvard University, then moved to Massachusetts General Hospital where he worked on the molecular biology of limb development. He was appointed to the faculty in the Department of Genetics at Harvard Medical School in 1989, and promoted to full professor in 1997 and chairman of the department in January 2007. == Entrepreneurial activities ==

In 2023, Dr. Cliff Tabin co-founded Somite Therapeutics, a biotechnology company that integrates artificial intelligence with stem cell biology to develop novel cell replacement therapies. Serving as a scientific co-founder, Tabin collaborates with other prominent scientists, including Olivier Pourquié, Allon Klein, and Jay Shendure, to advance the company's mission of producing human tissue for therapeutic applications using AI-driven models. Somite's flagship program, SMT-M01, targets Duchenne muscular dystrophy (DMD) and has received both Orphan Drug and Rare Pediatric Disease designations from the U.S. Food and Drug Administration. The company has also partnered with OmniaBio Inc., a cell and gene therapy contract development and manufacturing organization, to support the development and manufacturing of its cell therapy products. ==Research==

Tabin's research investigates the genetic regulation of vertebrate development, combining classical methods of experimental embryology with modern molecular and genetic techniques for regulating gene expression during embryogenesis. Previously Tabin has worked on retroviruses, homeobox genes, oncogenes, developmental biology and evolution. Early in his research he investigated limb regeneration in the salamander, and described the expression of retinoic acid receptor and Hox genes in the blastema. Comparative studies by Ann Burke in his lab showed that differences in boundaries of Hox gene expression correlated with differences in skeletal morphology. The Tabin laboratory adjoins the laboratory of Connie Cepko. ==Awards and honors==

Tabin was elected a Foreign Member of the Royal Society (ForMemRS) in 2014. His nomination reads: Tabin has also been awarded the Edwin Conklin Medal in 2012, the March of Dimes Prize in Developmental Biology jointly with Philip A. Beachy in 2008 and the NAS Award in Molecular Biology in 1999. He was elected a member of the National Academy of Sciences in 2007 and the American Academy of Arts and Sciences in 2000. He was elected a Member of the American Philosophical Society in 2019. ==Personal life==

Tabin is the son of Julius Tabin, a nuclear physicist who worked with Enrico Fermi on the Manhattan Project in Los Alamos National Laboratory in New Mexico during World War II. He has a brother, Geoff Tabin, and two children. Tabin appears as himself in a BBC Horizon programme titled Hopeful Monsters. ==References==